Replicel Life Sciences Inc
XTSX:RP

Watchlist Manager
Replicel Life Sciences Inc Logo
Replicel Life Sciences Inc
XTSX:RP
Watchlist
Price: 0.015 CAD
Market Cap: 954.8k CAD
Have any thoughts about
Replicel Life Sciences Inc?
Write Note

Operating Margin
Replicel Life Sciences Inc

-387.7%
Current
-477%
Average
3.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-387.7%
=
Operating Profit
-1.4m
/
Revenue
353.7k

Operating Margin Across Competitors

Country CA
Market Cap 921.4k CAD
Operating Margin
-388%
Country US
Market Cap 1.3T USD
Operating Margin
14%
Country US
Market Cap 207.5B USD
Operating Margin
17%
Country US
Market Cap 173.4B USD
Operating Margin
21%
Country KR
Market Cap 70.2T KRW
Operating Margin
31%
Country CH
Market Cap 40.8B CHF
Operating Margin
13%
Country US
Market Cap 39.2B USD
Operating Margin
14%
Country US
Market Cap 38.5B USD
Operating Margin
25%
Country US
Market Cap 26.5B USD
Operating Margin
28%
Country US
Market Cap 23.7B USD
Operating Margin
7%
Country US
Market Cap 23.6B USD
Operating Margin
20%

Profitability Report

View the profitability report to see the full profitability analysis for Replicel Life Sciences Inc.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-387.7%
=
Operating Profit
-1.4m
/
Revenue
353.7k
What is the Operating Margin of Replicel Life Sciences Inc?

Based on Replicel Life Sciences Inc's most recent financial statements, the company has Operating Margin of -387.7%.